Progenics Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report

Progenics Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Progenics Pharmaceuticals, Inc. (Progenics or 'the company') is a biopharmaceutical company focused on the development of innovative medicines and other technologies for targeting and treating cancer. Its product portfolio includes therapeutic agents such as AZERDA and PSMA TTC that are designed to precisely target cancer and prostate-specific membrane antigen ("PSMA") targeted imaging agents including PyL used to treat prostate cancer. In addition, it also enters into licensing agreements with the University of Zurich and the Paul Scherrer, The University of Western Ontario, Johns Hopkins University and with Bayers subsidiary for acquiring worldwide sublicensable rights to enhance their product candidates. The company is headquartered in New York, the US.

Scope

– Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis

– An in-depth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments

– Intelligence on Progenics Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Progenics Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Progenics Pharmaceuticals, Inc.: Company Overview

Progenics Pharmaceuticals, Inc.: Overview and Key Facts

Progenics Pharmaceuticals, Inc.: Overview

Progenics Pharmaceuticals, Inc.: Key Facts

Progenics Pharmaceuticals, Inc.: Key Employees

Progenics Pharmaceuticals, Inc.: Key Employee Biographies

Progenics Pharmaceuticals, Inc.: Major Products and Services

Progenics Pharmaceuticals, Inc.: Company History

Progenics Pharmaceuticals, Inc.: Management Statement

Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries

Progenics Pharmaceuticals, Inc.: Key Competitors

Progenics Pharmaceuticals, Inc.: Company Analysis

Progenics Pharmaceuticals, Inc.: Business Description

Progenics Pharmaceuticals, Inc.: SWOT Analysis

Progenics Pharmaceuticals, Inc.: SWOT Overview

Progenics Pharmaceuticals, Inc.: Strengths

Progenics Pharmaceuticals, Inc.: Weaknesses

Progenics Pharmaceuticals, Inc.: Opportunities

Progenics Pharmaceuticals, Inc.: Threats

Progenics Pharmaceuticals, Inc.: Corporate Financial Deals Activity

Progenics Pharmaceuticals, Inc.: Financial Deals Overview

Progenics Pharmaceuticals, Inc.: Targets and Partners

Progenics Pharmaceuticals, Inc.: Top Deals 2017 - 2021YTD*

Progenics Pharmaceuticals, Inc.: Advisors

Progenics Pharmaceuticals, Inc.: Top Legal Advisors

Progenics Pharmaceuticals, Inc.: Top Financial Advisors

Progenics Pharmaceuticals, Inc.: Mergers and Acquisitions

Progenics Pharmaceuticals, Inc.: Capital Raising

Progenics Pharmaceuticals, Inc.: Partnership

Progenics Pharmaceuticals, Inc.: Private Equity and Ownership

Progenics Pharmaceuticals, Inc.: Recent Developments

Progenics Pharmaceuticals, Inc.: News and Events Summary

Progenics Pharmaceuticals, Inc.: Corporate Governance

Progenics Pharmaceuticals, Inc.: Financial Performance

Progenics Pharmaceuticals, Inc.: Market Developments

Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events

Progenics Pharmaceuticals, Inc.: Research & Development

Progenics Pharmaceuticals, Inc.: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Progenics Pharmaceuticals, Inc.: Key Facts

Table 2: Progenics Pharmaceuticals, Inc.: Key Employees

Table 3: Progenics Pharmaceuticals, Inc.: Company History

Table 4: Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 5: Progenics Pharmaceuticals, Inc.: Key Competitors

Table 6: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (TTM*)

Table 7: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (2017 – YTD*2021)

Table 8: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size – Value (US$m)

Table 9: Progenics Pharmaceuticals, Inc.: Targets and Partners

Table 10: Progenics Pharmaceuticals, Inc.: Top Deals 2017 – 2021YTD*

Table 11: Progenics Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)

Table 12: Progenics Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)

Table 13: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2017 – YTD*2021)

Table 14: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2017 – YTD*2021)

Table 15: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2017 – YTD*2021)

Table 16: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2017 – YTD*2021)

Table 17: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2017 – YTD*2021)

Table 18: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2017 – YTD*2021)

Table 19: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2017 – YTD*2021)

Table 20: Progenics Pharmaceuticals, Inc.: News and Events Summary

Table 21: Progenics Pharmaceuticals, Inc.: Corporate Governance

Table 22: Progenics Pharmaceuticals, Inc.: Financial Performance

Table 23: Progenics Pharmaceuticals, Inc.: Market Developments

Table 24: Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 25: Progenics Pharmaceuticals, Inc.: Research & Development

Table 26: Progenics Pharmaceuticals, Inc.: Strategy and Operations

List of Figures

List of Figures

Figure 1: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (2017 – YTD*2021)

Figure 3: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size – Value (US$m)

Figure 4: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2017 – YTD*2021)

Figure 5: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2017 – YTD*2021)

Figure 6: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2017 – YTD*2021)

Figure 7: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2017 – YTD*2021)

Figure 8: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2017 – YTD*2021)

Figure 9: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2017 – YTD*2021)

Figure 10: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2017 – YTD*2021)

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports